MoneyWorks4Me

Supriya Lifescience informs about analyst meet

19 Sep 2022 Evaluate
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, Supriya Lifescience has informed that he officials of Supriya Lifescience ('Company') had attended the Motilal Oswal Annual Global Investor Conference on September 19, 2022 physically.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..